Preimplantation Genetic Testing Market Trends

Statistics for the 2023 & 2024 Preimplantation Genetic Testing market trends, created by Mordor Intelligence™ Industry Reports. Preimplantation Genetic Testing trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License
Team License
Corporate License
Book before:

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Market Trends of Preimplantation Genetic Testing Industry

This section covers the major market trends shaping the Preimplantation Genetic Testing Market according to our research experts:

IVF Prognosis is Expected to Hold a Significant Market Share in the Preimplantation Genetic Testing Market Over the Forecast Period

Invitro fertilization(IVF) is a method of assisted reproduction and treatment for specific genetic and fertility issues. The prognosis for IVF is a necessary procedure to inspect the medical condition of the embryos by preimplantation genetic testing methods. Thus, preimplantation genetic testing plays a crucial role in the IVF prognosis, thereby contributing to the growth of the studied segment. The IVF prognosis segment is expected to account for a significant share of the preimplantation genetic testing market. It is mainly due to the high number of invitro fertilization procedures owing to the increased demand for preimplantation genetic testing procedures.

For instance, according to the MayoClinic article updated in May 2022, globally, 10-12% of couples have difficulty conceiving, which is expected to increase gradually in the coming years. IVF accounts for 1.6% and 4.5% of all US and Europe live births, respectively. Also, the same article quoted that approximately 25% to 35% of infertile women have a subperitoneal disease. Pelvic inflammatory disease (PID) is the most common cause of infertility, and poor semen quality in men is the sole cause of infertility in 20% of couples. Such a high burden of people having difficulty conceiving and a decrease in fertility rates contributes to the segment's growth.

Additionally, the rising product launches by various market players are expected to drive the growth of the studied segment over the forecast period. For instance, in July 2022, GenEmbryonics launched the commercial whole genome sequencing test for effectively screening all genetic diseases in IVF embryos. This comprehensive testing clarifies the embryo's genome sequence, allowing disease-causing mutations to be identified and screened.

Thus, factors such as rising infertility, increasing preference for IVF procedures, and growing product launches for IVF prognosis are expected to drive the growth of the studied segment over the forecast period.

Pre-Implantation Genetic Testing Market : Estimated Fertility Rate Per Woman, Global, 2021 -2050

North America is Expected to Hold a Significant Share in the Preimplantation Genetic Testing Market Over the Forecast Period

North America is expected to dominate the preimplantation genetic testing market. The dominance is due to a growing volume of cases of chromosome abnormality leading to various genetic disorders. Additionally, the increasing consumer awareness and the presence of significant market players in this region are also driving factors for the growth of the market in this region.

According to the Centers for Disease Control and Prevention (CDC) report in April 2021, about 6,000 babies born in the US have down syndrome every year. Similarly, the Province of British Columbia, Canada, an article published in February 2021, mentioned that in Canada, one in every 750 live babies born has Down syndrome. Additionally, the data published in Facets Journal in November 2021 noted that rare diseases affect approximately 1 in 12 Canadians, and most have underlying genetic causes. It, in turn, resulted in high demand for earlier diagnoses to identify the genetic defects in embryos, thus driving the market in the region.

The increasing market player's activities, such as partnerships, mergers, and collaborations in North America to develop products, are also expected to contribute to the market's growth. For instance, in October 2022, Ovation Fertility partnered with Genomic Prediction to license the LifeView PGT platform for genetic testing. This Lifeview PGT provides the most comprehensive currently available genetic test of the preimplantation embryo.

Thus, the high burden of genetic diseases and increasing market players' activities, coupled with the rising awareness regarding preimplantation genetic testing in North American countries, is expected to drive the market's growth in this region over the forecast period.

Pre-Implantation Genetic Testing Market- Growth Rate by Region

Preimplantation Genetic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)